Close

Titration Assays for Cancer Vaccine

Viral vectors for cancer vaccines or gene therapy offer a number of advantages, vaccine-based products are being restored based on gene and cell therapy and due to the introduction of next-generation transfer vectors including adenovirus, adeno-associated virus, and lentivirus. The quality and purity/efficacy of the vectors are the most important, and as part of the carrier test package, the determination of viral titer is a critical measurement.

Creative Biolabs utilizes powerful economical plate-based flow cytometry assays, plaque and endpoint dilution assays for viral titer determination to accurately optimize infection parameters for protein production in cell cultures for viral infection.

Plaque Assay

Plaque assays are classical bioassays used to measure viral infectivity in test articles and can be used to purify cloned virus populations or to determine viral titers to be per gram of plaque forming units (pfu/ml). We can count individual plaques obtained from virus stocks of different dilutions to determine the viral titer (pfu/ml) for a given transfusion or virus stock.

End Point Dilution Assay

Endpoint dilution assays (EPDA) can be used in a variety of assays. Creative Biolabs can use 96-well plate EPDA instead of plaque assay and plaque purification as a means of determining viral titers or identifying and purifying recombinant viruses. The improved 12-well plate EPDA can be used as a routine method for viral titers determination; it can be used to estimate the efficiency of initial co-transfection, identify infected cells, approximate viral titers, and amplify viral titers.

Flow Cytometry-Based Immuno-Titration

An immunotitration method based on flow cytometry has been developed by Creative Biolabs to determine the infectious unit (IU) and transduction unit (TU) of the viral vector. This titration method counts infected cells by measuring the expression of viral proteins of TU of IU and transgenic proteins in individual cells after staining with fluorescent conjugated antibody. Its advantages are convenience, rapidity and accuracy.

TCID50 Assay

The TCID50 assay (tissue culture infectious dose) is a quantitative assay system for determining viral titration. This procedure is performed to determine the infection titer of any virus that can cause cytopathic effect (CPE) in tissue culture, and to maintain the viability of cells in culture for 5 to 20 days.

For more details, please feel free to contact us for project quotations and more detailed information.

Online Inquiry

For any technical issues or products/services related questions, please leave your contacts as below, and our team will contact you at earliest convenience to let you know how we can be involved in your projects.

  • Verification code
    Click image to refresh the verification code.

Key Updates

Receive the latest news and insights to your inbox.